JSPR

JASPER THERAPEUTICS INC

JSPR·471871202·US·Common Stock·Healthcare - Biotechnology-Activist

JSPR (JASPER THERAPEUTICS INC) is held by 37 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($1.4M), MORGAN STANLEY ($1.2M), VANGUARD CAPITAL MANAGEMENT LLC ($1M). Net institutional sentiment: Mixed.

37
Holders
Avg rating(8 Elite)
$6.4M
Total Value
56% (43)
Fund Consensus
18 buying - 14 selling
JSPRSmart Money Verdict
View all
Held by 37 funds
8 elite
Who's Trading
ActivistMIMillennium Management LLC1.7%Jul 10, 2026
ActivistMorgan StanleyMorgan Stanley4.8%May 12, 2026
ActivistSOSoleus Capital Management, L.P.1.0%May 8, 2026
ActivistTHE GOLDMAN SACHS GROUP, INC.THE GOLDMAN SACHS GROUP, INC.0.5%May 8, 2026
ActivistICIntegrated Core Strategies (US) LLC5.8%Feb 25, 2026
ActivistThe Carlyle Group Inc.The Carlyle Group Inc.3.8%Feb 18, 2026
InsiderSAShizuru Judith AnneBuy $100KSep 22, 2025
InsiderMRMARTELL RONBuy $100KSep 22, 2025
InsiderWGWIGGANS THOMAS GBuy $100KSep 22, 2025
InsiderLSLucas SvetlanaBuy $49KSep 22, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.6M(+50.6%)$1.4M0.0%-71.65%
35
Decreased
1.3M(-32.3%)$1.2M0.0%-92.72%
0
New
1.2M$1M0.0%-56.39%
38
Unchanged
1.1M$934,1950.0%-96.91%
0
Increased
322,273(+488.1%)$282,3760.0%-58.81%
38
Increased
317,677(+50.0%)$278,3940.0%-94.60%
22
Increased
293,259(+0.1%)$256,8950.0%-96.69%
16
Increased
242,061(+2.5%)$212,0930.0%-96.78%
16
Decreased
177,500(-21.9%)$155,5260.0%-77.43%
0
New
149,943$131,3500.0%-56.39%
34
Decreased
81,117(-35.8%)$71,0580.0%-86.20%
0
Decreased
64,915(-77.0%)$56,8790.0%-70.61%
0
Increased
51,428(+2.0%)$45,0610.0%-76.19%
21
New
45,656$40,1770.0%-56.39%
31
Unchanged
44,699$39,1650.0%-97.04%
0
Unchanged
40,850$35,7930.0%-79.97%
0
New
39,431$34,5490.0%-56.39%
27
Unchanged
34,576$30,2950.0%-97.17%
0
New
29,273$25,6430.0%-56.39%
29
Increased
26,131(+83.3%)$22,8960.0%-63.31%
29

Showing 1-20 of 43

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used